drugset / Trial / NCT04214301

An Open-Label Preference Evaluation of BLI800

NCT04214301

Phase 4 Completed 40 enrolled Braintree Laboratories
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate patient experience ratings of BLI800 in adult patients undergoing colonoscopy.

Timeline

Start
2019-09-24
Primary completion
2019-11-21
Completion
2019-11-21

Drugs

EvaluationDrugModalityDoseRoute
Subject BLI800 Unknown

Indications

No indication recorded.